ARTELO BIOSCIENCES, INC.
Data quality: 83%
ARTL
Nasdaq
Manufacturing
Chemicals
$6.51
▼
$0.33
(-4.82%)
Mkt Cap: 5.32 M
Price
$6.51
Mkt Cap
5.32 M
Day Range
$6.20 — $6.84
52-Week Range
$2.96 — $85.80
Volume
185,790
Open $6.47
50D / 200D Avg
$4.91
32.49% above
50D / 200D Avg
$14.68
55.65% below
Quick Summary
Key Takeaways
Negative free cash flow of -8.52 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.38
Interest Coverage-58.78
Valuation
PE (TTM)
-0.41
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.4 | -2.0 |
| P/B | — | 5.1 |
| ROE % | — | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -12.88 M |
| ROE | N/A | ROA | -298.68% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -8.52 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.38 |
| Interest Coverage | -58.78 | Asset Turnover | N/A |
| Working Capital | -3.03 M | Tangible Book Value | -2.67 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.41 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -160.17% | ||
| Market Cap | 5.32 M | Enterprise Value | 5.32 M |
| Per Share | |||
| EPS (Diluted TTM) | -12.52 | Revenue / Share | N/A |
| FCF / Share | -10.43 | OCF / Share | -10.43 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 66.15% |
| SBC-Adj. FCF | -9.50 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -12.88 M | -9.83 M | -9.29 M | -10.08 M | -7.44 M |
| EPS (Diluted) | -12.52 | -3.05 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -11.40 M | -10.11 M | -9.93 M | -10.29 M | -7.44 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.42 M | 5.99 M | 5.70 M | 4.32 M | 2.84 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 194,000.0 | — | 0.0 | 5,000.0 | — |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.80 M | 4.70 M | 13.04 M | 20.42 M | 12.64 M |
| Total Liabilities | 4.07 M | 1.84 M | 1.29 M | 1.02 M | 593,000.0 |
| Shareholders' Equity | -1.27 M | 2.86 M | 11.75 M | 19.40 M | 12.04 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 600,000.0 | — | — | 6.89 M | 6.63 M |
| Current Assets | 695,000.0 | 2.56 M | 10.98 M | 18.32 M | 10.32 M |
| Current Liabilities | 4.04 M | 1.77 M | 1.29 M | 998,000.0 | 526,000.0 |
{"event":"ticker_viewed","properties":{"ticker":"ARTL","listing_kind":"stock","pathname":"/stocks/artl","exchange":"Nasdaq","country":"US"}}